Can I Take Weight Loss Medication With My Other Prescriptions?

What are the main types of prescription weight-loss medication?

Prescription weight-loss medications work through several different mechanisms, and each has its own interaction profile:

GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide): mimic a gut hormone that slows stomach emptying, reduces appetite, and lowers blood sugar. Semaglutide (sold as Wegovy for weight management and Ozempic for diabetes) and tirzepatide (sold as Zepbound for weight management and Mounjaro for diabetes) are in this class 1Ref 1Novo Nordisk (2024).WEGOVY (semaglutide) injection — FDA Prescribing Information.FDA prescribing information for semaglutide (Wegovy) including gastroparesis effect, drug interaction profile, and contraindications2Ref 2Eli Lilly (2022).MOUNJARO (tirzepatide) injection — FDA Prescribing Information.FDA prescribing information for tirzepatide (Mounjaro/Zepbound) including drug interaction profile3Ref 3Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF (2021).Once-Weekly Semaglutide in Adults with Overweight or Obesity.Clinical evidence for semaglutide use in obesity, informing its mechanism and expected treatment context.

Stimulant-class drugs (phentermine, phentermine-topiramate): suppress appetite through stimulant mechanisms, raising heart rate and blood pressure.

Naltrexone-bupropion (Contrave): affects reward and appetite signaling; contains both an antidepressant (bupropion) and an opioid blocker (naltrexone).

Orlistat: blocks fat absorption in the gut; can reduce absorption of fat-soluble vitamins and some medications.

Each mechanism creates a distinct set of interaction concerns 4Ref 4National Institute of Diabetes and Digestive and Kidney Diseases (2023).Prescription Medications to Treat Overweight and Obesity.Overview of all prescription weight-loss medication classes, their mechanisms, and interaction considerations including stimulant-class and combination drugs.

How do GLP-1 drugs affect other medications?

GLP-1 medications substantially slow the rate at which the stomach empties food and pills into the small intestine. This delays absorption of oral medications — and for drugs where timing matters, delayed absorption can reduce effectiveness or create unpredictable blood levels.

Medications most affected by this gastroparesis-like effect include: - Thyroid medication (levothyroxine): timing-sensitive; even a modest delay in absorption can shift thyroid levels - Oral contraceptives: best taken at a consistent time relative to your GLP-1 dose - Seizure medications: where stable blood levels are clinically important - Blood thinners (especially warfarin): dietary changes from nausea, absorption shifts, and weight loss itself can all alter warfarin levels

The practical guidance: take time-sensitive oral medications consistently — same time, same conditions — ideally before your GLP-1 dose. Your prescriber may recommend specific spacing. This is especially relevant in the first weeks when the stomach-slowing effect is most noticeable 1Ref 1Novo Nordisk (2024).WEGOVY (semaglutide) injection — FDA Prescribing Information.FDA prescribing information for semaglutide (Wegovy) including gastroparesis effect, drug interaction profile, and contraindications2Ref 2Eli Lilly (2022).MOUNJARO (tirzepatide) injection — FDA Prescribing Information.FDA prescribing information for tirzepatide (Mounjaro/Zepbound) including drug interaction profile.

What is the risk with insulin and diabetes medications?

GLP-1 drugs lower blood sugar on their own. When combined with insulin or sulfonylureas (glipizide, glyburide), the combined effect can push blood sugar too low — a condition called hypoglycemia. This is one of the most clinically important interaction considerations for GLP-1 therapy.

Prescribers typically reduce the insulin or sulfonylurea dose when starting a GLP-1 medication. If you are on these medications, closer blood sugar monitoring — especially early in treatment — is important 5Ref 5American Diabetes Association Professional Practice Committee (2024).Standards of Care in Diabetes—2024.ADA guidance on GLP-1 use with diabetes medications including recommendation to reduce insulin or sulfonylurea doses to prevent hypoglycemia when starting GLP-1 therapy.

Metformin and DPP-4 inhibitors carry less risk of hypoglycemia on their own, so the concern is less acute with those combinations 4Ref 4National Institute of Diabetes and Digestive and Kidney Diseases (2023).Prescription Medications to Treat Overweight and Obesity.Overview of all prescription weight-loss medication classes, their mechanisms, and interaction considerations including stimulant-class and combination drugs.

What about the older stimulant-class and combination weight-loss drugs?

Phentermine and phentermine-topiramate have stimulant properties that raise heart rate and blood pressure. They interact with MAOIs, other stimulants, and some antidepressants, and are generally avoided in people with a history of cardiovascular disease. Topiramate (in the combination drug) also interacts with other CNS medications and can reduce the efficacy of oral contraceptives.

Naltrexone-bupropion (Contrave) cannot be taken by anyone using opioid pain medications or on opioid maintenance therapy — the naltrexone component blocks opioid receptors and can precipitate withdrawal. Bupropion also inhibits a liver enzyme, affecting levels of several other medications 4Ref 4National Institute of Diabetes and Digestive and Kidney Diseases (2023).Prescription Medications to Treat Overweight and Obesity.Overview of all prescription weight-loss medication classes, their mechanisms, and interaction considerations including stimulant-class and combination drugs.

What does weight loss itself change about other medications?

An often-overlooked aspect: significant weight loss changes how the body processes medications, independent of direct drug interactions.

• Blood pressure often drops as weight decreases — antihypertensive doses may need to come down
• Blood sugar control frequently improves — diabetes medication doses may need to decrease
• Medications dosed based on body weight may need adjustment

Your prescriber should plan to revisit your other medication doses periodically as weight loss progresses. This is an ongoing conversation throughout treatment, not a one-time check 4Ref 4National Institute of Diabetes and Digestive and Kidney Diseases (2023).Prescription Medications to Treat Overweight and Obesity.Overview of all prescription weight-loss medication classes, their mechanisms, and interaction considerations including stimulant-class and combination drugs.

What should I bring to my prescriber before starting?

A complete medication review is essential before starting any weight-loss prescription. Bring:

• A complete and updated list of all prescriptions, OTC drugs, supplements, vitamins, and herbal products — with doses and how often you take each
• Your most recent blood sugar readings if you have diabetes
• Your blood pressure readings if you monitor at home
• Any personal or family history of pancreatitis, thyroid cancer, or medullary thyroid carcinoma (relevant to GLP-1 prescribing decisions)

Specifically flag: diabetes medications (especially insulin and sulfonylureas), blood thinners (especially warfarin), thyroid medication, oral contraceptives, any opioid medications, antidepressants, and seizure medications 4Ref 4National Institute of Diabetes and Digestive and Kidney Diseases (2023).Prescription Medications to Treat Overweight and Obesity.Overview of all prescription weight-loss medication classes, their mechanisms, and interaction considerations including stimulant-class and combination drugs.